Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.34 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15300808 | 0.79 | SLC6A2 (0.40) | TSHRCYP2C19SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL8234528 | 0.75 | DRD2 (0.44) | TSHRMAOBCYP19A1MAOA | |
| SCHEMBL6384626 | 0.75 | CYP2C19 (0.58) | TSHRCYP2C19MEN1KMT2ASLC6A2 | |
| SCHEMBL15349821 | 0.74 | CHRNB4 (0.40) | TSHR | |
| SCHEMBL5156811 | 0.71 | TSHR (0.50) | TSHRCYP2C19MEN1KMT2ASLC6A2 | |
| SCHEMBL1176630 | 0.71 | TSHR (0.50) | TSHRCYP2C19MEN1KMT2ASLC6A2 | |
| SCHEMBL987488 | 0.71 | — | — | |
| SCHEMBL1943997 | 0.71 | — | — | |
| SCHEMBL21026 | 0.71 | — | — | |
| SCHEMBL28467238 | 0.71 | TSHR (1.00) | TSHRCYP2C19MEN1KMT2ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4214303-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-07-26 | — | — | EP | claimed |
| WO-2022058048-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-03-24 | — | — | WO | claimed |
| US-12486471-B2 | Perfume formulation for delivery system | FIRMENICH SA (CH) | 2025-12-02 | — | — | US | disclosed |
| US-12480075-B2 | Perfume delivery system | FIRMENICH SA (CH) | 2025-11-25 | — | — | US | disclosed |
| US-12377407-B2 | Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) | 2025-02-06 | — | — | US | disclosed |
| EP-4433451-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | Ecole Nationale Supérieure de Chimie de Rennes (FR) | 2024-09-25 | — | — | EP | disclosed |
| EP-4214303-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023088919-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) | 2023-05-25 | — | — | WO | disclosed |
| US-20230040744-A1 | Perfume Formulation for Delivery System | FIRMENICH SA (CH) | 2023-02-09 | — | — | US | disclosed |
| US-20230036889-A1 | Perfume Delivery System | FIRMENICH SA (CH) | 2023-02-02 | — | — | US | disclosed |
| WO-2013010676-A2 | SUPPORTED IONIC LIQUID PHASE CATALYST | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2013-01-24 | — | — | WO | disclosed |
| WO-2011117571-A1 | RUTHENIUM COMPLEXES FOR USE IN OLEFIN METATHESIS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2011-09-29 | — | — | WO | disclosed |
| US-20110009621-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | Raap Polymere GmbH (DE) | 2011-01-13 | — | — | US | disclosed |
| US-20110009621-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | Raap Polymere GmbH (DE) | 2011-01-13 | — | — | US | disclosed |
| US-20090170692-A1 | CATALYSTS FOR RING-CLOSING METATHESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH | 2009-07-02 | — | — | US | disclosed |
| WO-2009009597-A1 | WATER SOLUBLE OLEFIN METATHESIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-01-15 | — | — | WO | disclosed |
| WO-2009009597-A1 | WATER SOLUBLE OLEFIN METATHESIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-01-15 | — | — | WO | disclosed |
| WO-2007117221-A1 | CATALYSTS FOR RING CLOSING METATHESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007065907-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | RAPP POLYMERE GMBH (DE) | 2007-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009621-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | SCO2, SOD1, PPIF | TSHR 4727/4885CYP2C19 938/4885MEN1 266/4885 |
| US-12377407-B2 | Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis | PPOX, CYBA, CYBB | TSHR 4806/4885CYP2C19 883/4885MEN1 1935/4885 |
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | SQLE, SYMPK, FDFT1 | TSHR 4508/4885CYP2C19 1923/4885MEN1 700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.